Oncology Drug Advisory Committee

Results: 151



#Item
81November 5, 2013, Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) Webcast Recording The Center for Drug Evaluation and Research (CDER) provided a live webcast of the No

November 5, 2013, Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) Webcast Recording The Center for Drug Evaluation and Research (CDER) provided a live webcast of the No

Add to Reading List

Source URL: www.fda.gov

    82FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETING THE KENNEDY BALLROOM, CROWNE PLAZA HOTEL, 8777 GEORGIA AVENUE, SILVER SPRING MARYLAND

    FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) ANTIVIRAL DRUGS ADVISORY COMMITTEE MEETING THE KENNEDY BALLROOM, CROWNE PLAZA HOTEL, 8777 GEORGIA AVENUE, SILVER SPRING MARYLAND

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2007-05-18 16:43:12
    83November 4, 2013, Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) Webcast Information The Center for Drug Evaluation and Research (CDER) plans to provide a free of char

    November 4, 2013, Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) Webcast Information The Center for Drug Evaluation and Research (CDER) plans to provide a free of char

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    84Summary Minutes of the Oncologic Drugs Advisory Committee Meeting September 14, 2011 Location: FDA White Oak Campus, Building 31, the Great Room, White Oak Conference Center (Rm. 1503), 10903 New Hampshire Avenue, Silver

    Summary Minutes of the Oncologic Drugs Advisory Committee Meeting September 14, 2011 Location: FDA White Oak Campus, Building 31, the Great Room, White Oak Conference Center (Rm. 1503), 10903 New Hampshire Avenue, Silver

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    85Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen

    Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    86Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen

    Food and Drug Administration Center for Drug Evaluation and Research Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting FDA White Oak Campus, Building 31, the Great Room, White Oak Conferen

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    87Federal Register / Vol. 69, No[removed]Thursday, December 9, [removed]Notices Inc., at 12th and Lincoln Sts. SW., Le Mars, IA[removed]The test products will be distributed by Wells’ Dairy, Inc., throughout the States of Io

    Federal Register / Vol. 69, No[removed]Thursday, December 9, [removed]Notices Inc., at 12th and Lincoln Sts. SW., Le Mars, IA[removed]The test products will be distributed by Wells’ Dairy, Inc., throughout the States of Io

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2004-12-09 08:51:22
    88U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

    U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    89ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

    ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    90ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

    ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

    Add to Reading List

    Source URL: www.fda.gov

    Language: English